Log In
BCIQ
Print this Print this
 

MIV-711

  Manage Alerts
Collapse Summary General Information
Company Medivir AB
DescriptionReversible small molecule inhibitor of cathepsin K (CTSK)
Molecular Target Cathepsin K (CTSK)
Mechanism of ActionCathepsin K inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/31/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today